Antithrombotic Therapy and Vascular Access Site
نویسندگان
چکیده
منابع مشابه
Stents, antithrombotic agents and vascular complications. Does site of arterial access make a difference?
growing extent direct thrombin inhibitors such as hirudin and hirulog, and the newer low molecular weight heparins, principally enoxaparin and dalteparin, are also being used during the procedure. In the EPIC study, the first large trial with abciximab in coronary intervention, a full dose heparin bolus was given to achieve an activated clotting time of 300–350 s. This resulted in a much higher...
متن کاملComparison of Celox powder and conventional dressing on hemostasis of vascular access site in hemodialysis patients
Background: Common measures to stop bleeding can run the risk of clotting and thrombosis due to prolonged application of pressure. Topical homeostatic agents have an important role in decreasing time to hemostasis and consequently prevention of the complications. Aim: the aim of this study was to compare Celox powder and conventional bandage on time to hemostasis in the vascular access site i...
متن کاملRadiation exposure and vascular access site.
We read with interest the article by Brasselet et al. comparing operator radiation exposure with different vascular access sites, namely radial vs. femoral access, during the performance of coronary angiograms or other percutaneous coronary interventions (PCI). This important concern merits attention, and has been debated extensively over the last few years. As mentioned by the authors, specifi...
متن کاملEffect of combination of alcohol and Betadine on the severity of inflammation in the vascular access site in hemodialysis patients
Background: Inflammation in the vascular access site results in infection, which is the second leading cause of death in hemodialysis patients. However, there is no specific protocol available for sterilization before vascular access in such patients. Aim: to determine the effect of the combination of alcohol and Betadine on the severity of inflammation in the vascular access site in hemodialys...
متن کاملImpact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
BACKGROUND The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial demonstrated that bivalirudin monotherapy significantly reduces major bleeding compared with heparin (unfractionated or enoxaparin) or bivalirudin plus a glycoprotein IIb/IIIa inhibitor in acute coronary syndromes. Whether vascular closure devices (VCD) impact these results is unknown. Therefore, this st...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Cardiovascular Interventions
سال: 2016
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2016.08.021